EHC
Encompass Health CorpPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Apr 30 ▲ Encompass Health reported Q1 2026 results with net operating revenue…
- May 11 to May 15 ▼ 2 days of insider sells: $3.0M by 2 insiders, avg $106.78
- May 28 TD Cowen initiates
- Aug 5 ▲ Encompass Health reported Q2 2026 diluted EPS of $1.55, beating cons…
- Aug 10 ▼ 3 insiders sell $25.2M at $125.48
- Aug 31 ▼ 2 insiders sell $1.2M at $121.01
- Oct 22 Dividend: Encompass Health declares dividend on common stock
- Oct 28 ▲ Encompass Health reported Q3 2026 net operating revenue of $1,609.5M…
- Oct 28 ▲ Encompass Health reported Q3 2026 adjusted EPS of $1.52, beating the…
- Oct 28 ▲ Earnings: EHC Q3 2026 Earnings: EPS $1.52 (+10.6% vs est)
Signal stack
Where each data set points today.
- InsidersBEARISH
5 insiders sold $29.5M.
- InstitutionsMIXED
Q2 2026: 30 added (0 new), 25 trimmed or exited.
- AnalystsBULLISH
17 of 18 rate it Buy or better. Median target $155.00 (+9%).
- Short sellersSTEADY
Short interest +9.1% to 3.61M shares. 2.7 days to cover, ≈3.7% of shares.
- TrendUPTREND
12% above its 50-day average. New closing high $142.51 on Nov 10.
- SocialQUIET
No Reddit mentions this week. Last mention Nov 9.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| CITADEL ADVISORS LLC | DOUBLED | $259.1M |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | ADD | $116.4M |
| MORGAN STANLEY | ADD | $115.9M |
| AMERICAN CENTURY COMPANIES INC | ADD | $106.2M |
| BROWN ADVISORY INC | ADD | $102.4M |
| Holocene Advisors, LP | DOUBLED | $98.8M |
| MILLENNIUM MANAGEMENT LLC | ADD | $81.4M |
| JANE STREET GROUP, LLC | DOUBLED | $58.9M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
18 analystsPrice is inside the target range. Median implies +9%.Targets as of Nov 16, 2026.
| Date | Firm | Rating |
|---|---|---|
| Oct 30, 2026 | UBS MAINTAIN | Buy |
| Oct 30, 2026 | TD Cowen MAINTAIN | Buy |
| Oct 30, 2026 | Truist Securities REITERATE | Buy |
| Oct 30, 2026 | Keybanc MAINTAIN | Overweight |
| Oct 29, 2026 | Barclays MAINTAIN | Overweight |
| Aug 10, 2026 | TD Cowen MAINTAIN | Buy |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Reidy Christopher R Director Oct 19, 2026 | AWARD | $36.0K |
Christie Edward M III Director Oct 19, 2026 | AWARD | $28.0K |
KATZ LESLYE G Director Oct 15, 2026 | AWARD | 81 sh |
O'Connor Kevin J. Director Oct 15, 2026 | AWARD | 18 sh |
Hayes Cain A Director Oct 15, 2026 | AWARD | 4 sh |
Reidy Christopher R Director Oct 15, 2026 | AWARD | 20 sh |
Christie Edward M III Director Oct 15, 2026 | AWARD | 11 sh |
HERMAN JOAN E Director Oct 15, 2026 | AWARD | 81 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Washington
Short side
FINRA· Oct 30, 2026SecBot reports
13 filings · 1 press release · 4 bullish · 1 bearish · 1 mixed · 7 neutral- NEUTRAL 8-KNov 6, 2026
Encompass Health disclosed the indefinite closure of its 90-bed Sea Pines Rehabilitation Hospital…
Monitor updates on the joint venture's decision to refurbish or replace Sea Pines and any insurance recovery. The reaffirmed guidance suggests management views the financial impact as manageable…
- BULLISH 8-KOct 28, 2026
Encompass Health reported Q3 2026 net operating revenue of $1,609.5M (up 8.9% YoY) and adjusted…
The raised guidance midpoint for adjusted EPS ($6.30) implies Q4 adjusted EPS of approximately $1.63, above the Q3 run rate. Monitor the billing system conversion disruption (bad debt up 80bps) and…
- BULLISH PRESS-RELEASEOct 28, 2026
Encompass Health reported Q3 2026 adjusted EPS of $1.52, beating the $1.36 consensus by 11.8%, on…
The raised full-year guidance and strong operational metrics (discharge growth, revenue per discharge, cash flow) suggest continued momentum. Monitor the Q4 2026 earnings call for updates on…
- MIXED INST-CLUSTEROct 27, 2026
In Q2 2026, 30 institutional buyers accumulated $176.5M in net new EHC positions while 25 sellers…
The cluster shows active managers accumulating while quant funds trimming, suggesting a fundamental thesis divergence. Monitor next earnings for catalyst validation; the 45-day reporting lag means…
All EHC filing & press-release reports (14)
- 8-K reportNov 6, 2026
- 8-K reportOct 28, 2026
- PRESS-RELEASE reportOct 28, 2026
- INST-CLUSTER reportOct 27, 2026
- INST-CLUSTER reportOct 23, 2026
- PRESS-RELEASE reportOct 22, 2026
- PRESS-RELEASE reportOct 1, 2026
- CLUSTER reportSep 1, 2026
- CLUSTER reportAug 11, 2026
- PRESS-RELEASE reportAug 5, 2026
- PRESS-RELEASE reportJul 9, 2026
- 8-K reportJun 1, 2026
- 8-K reportMay 15, 2026
- 8-K reportApr 30, 2026